Pharma out-licensing is a strategic approach where a pharmaceutical company licenses its assets, such as drugs or technologies, to external partners. The process and key steps of out-licensing are crucial for companies looking to expand their reach, enhance their product portfolios, and capitalize within the industry. This guide streamlines the out-licensing process, regardless of experience […]
Read More →In the dynamic landscape of the pharma industry, navigating the in-licensing process is a strategic imperative for companies seeking to strengthen their products. This complex journey involves identifying promising assets, negotiating agreements, and ultimately integrating external innovations. In-licensing refers to a formal collaboration where one company provides financial support to another to develop and launch […]
Read More →The development of new drugs is becoming more expensive and needs infrastructure and efficient resources so, licensing collaborations are becoming a favorable option for many global pharmaceutical companies. These licensing options help companies offset to research and development investments and bypass the cumbersome innovation and development process. As per the global data, in the pharmaceutical […]
Read More →